Home/Filings/4/0000899243-22-010294
4//SEC Filing

GARNER CAM L 4

Accession 0000899243-22-010294

CIK 0001375151other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 7:06 PM ET

Size

15.5 KB

Accession

0000899243-22-010294

Insider Transaction Report

Form 4
Period: 2022-03-07
GARNER CAM L
Director
Transactions
  • Disposition from Tender

    Common Stock

    2022-03-0741,0000 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-03-0720,0000 total
    Exercise: $8.99Exp: 2026-07-12Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-03-0720,0000 total
    Exercise: $12.75Exp: 2027-05-22Common Stock (20,000 underlying)
  • Disposition from Tender

    Common Stock

    2022-03-0740,8430 total(indirect: By LLC)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-03-0722,0000 total
    Exercise: $17.83Exp: 2031-05-26Common Stock (22,000 underlying)
Footnotes (3)
  • [F1]This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 18, 2022, (the "Merger Agreement"), among UCB S.A., a societe anonyme formed under the laws of Belgium ("Parent"), Zinc Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Purchaser") and the Issuer, pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer (the "Merger") effective as of March 7, 2022 (the "Effective Time"). At the Effective Time, each issued and outstanding Share was canceled and converted into the right to receive $26.00 in cash (the "Cash Amount") plus a contingent value right ("CVR"), which CVR represents the right to receive a contingent payment of $2.00 which amount will become payable, if at all, if a specified milestone is achieved on or prior to December 31, 2023.
  • [F2]Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a "Company Option") with an exercise price less than $26.00 (each, an "In the Money Option"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an "Out of the Money Option"),
  • [F3](Continued from Footnote 2) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration.

Issuer

ZOGENIX, INC.

CIK 0001375151

Entity typeother

Related Parties

1
  • filerCIK 0001024007

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 7:06 PM ET
Size
15.5 KB